How Social Support Influences Weight Health for GLP-1 Users
As the healthcare industry innovates to maximize the GLP-1 experience for patients, there appears to be an important factor that’s arguably under-discussed: loneliness.
Read Article
What you need to know about GLP-1s, and how Omada can help
Glucagon-like peptide 1 (GLP-1) agonists are a class of medications that improves blood sugar control and drives weight loss. Omada is helping customers and prospects navigate this new space by ensuring members who choose to get a prescription are taking it in conjunction with our behavior change prevention and diabetes programs, as outlined by the FDA.
-
-
Loading, please wait
Error - something went wrong!
Become an Omada Insider, subscribe to our monthly newsletter
Thank you!
-
3 Reasons GLP-1 Care Must Consider the Entire MSK System, Not Just Muscle Mass
Most people know that GLP-1 care can impact muscle mass, but it's important to consider the entire MSK system. Find out 3 reasons why with Omada Health.
Read Article
-
GLP-1 Discontinuation: Real-World Perspectives on a Complex Journey
Omada Insights Lab surveyed and interviewed Omada members with a history of GLP-1 use to learn more about their unique needs and experiences.
Read Resource
-
Omada Health Publishes Findings from Consumer Survey of GLP-1 Users
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
-
The GLP-1 Journey
New consumer data indicates that sustaining weight loss and overall well-being requires intervention beyond the GLP-1
Read Resource
-
The Problem with BMI: Addressing Inequities in Obesity Screening
With its checkered past and at times questioned clinical merits, BMI’s ubiquity in modern healthcare should be carefully considered.
Read Resource
-
New GLP-1 Indications: What you need to know
This insightful webinar delves into the expanding role of GLP-1 medications in treating a wide range of chronic conditions beyond diabetes and obesity.
Watch Video
-
Omada Health’s Guide to GLP-1s | Q3 - Q4 2024
Omada drills into emerging details of the GLP-1 experience, including compounded GLP-1s, how to manage the drug’s impact on body composition, & ways to assess the value of virtual companion programs.
Read Article
-
Omada Health’s Guide to GLP-1 Weight Loss | Quantity vs. Quality
Omada delivers GLP-1 FAQs focusing on weight loss quantity vs. quality with timely data and insights for employers, health plans and benefit consultants.
Read Article
-
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
-
Analysis Shows GLP-1s Work Best with Behavior Change Support
Analysis shows GLP-1s are twice as effective with lifestyle support programs. Download this free report by Omada Health and Express Scripts to learn more.
Read Resource
-
Loading, please wait
Error - something went wrong!
Become an Omada Insider, subscribe to our monthly newsletter
Thank you!
-
Life With GLP-1s
Clinical and cultural conversations around obesity have long revolved around BMI (and its credibility), harmful stereotypes, issues of equity and the multi-million dollar weight loss industry.
Read Resource
-
How to Combat Muscle Loss While Taking GLP-1s
A side-effect of taking GLP-1s is a loss of muscle mass. Julie Mulcahy, PT, DPT, CAPP OB explores how to combat this with resistance exercises.
Read Article
-
New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
-
GLP-1 Demand Spotlights Existing Inequities in Obesity Care
Obesity is one of the clearest case studies of health disparities that exist in the U.S., having the biggest impact on Black and Hispanic adults, low-income populations, and people covered by Medicaid
Read Article
-
Life After GLP-1s: How to Prevent Weight Regain in Your Population
Weight is hard to lose, but harder to keep off. Even GLP-1 users won’t stay on them forever. What’s life like after GLP-1s? Tune into our webinar and find out.
Watch Video
-
When Will GLP-1 Prices Drop?
GLP-1 agonist medications have had impressive initial outcomes. However, the long-term effects on a patient’s health beyond the trial timelines and on the costs to the healthcare system are uncertain.
Read Article
-
Your GLP-1 Questions, Answered: Side Effects, Pipeline & Price
Following up on our first GLP-1s webinar this one will address employers' most pressing questions around the risks and side effects of GLP-1s.
Watch Video
-
A Tsunami of New GLP-1s May Hit the Market — What Does That Mean for Costs?
The price of GLP-1 medication is a concern for stakeholders throughout the healthcare industry. Omada breaks down the list of GLP-1s by FDA approval stage, & what more GLP-1s could mean for costs.
Read Article
-
Familiarize Yourself with GLP-1 Medications | Video Blog Part 1
GLP-1s are effective options for weight management, but costs and side effects matter. Dive into the history and overview of GLP-1s in our 2-minute video.
Watch Video
-
Loading More...
